Bemotrizinol

Bemotrizinol

SCHEMBL7526147

CCCCC(CC)COc1ccc(-c2nc(-c3ccc(OC)cc3)nc(-c3ccc(OCC(CC)CCCC)cc3O)n2)c(O)c1.c1cnnnc1

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.38
IDH1 O75874 1/20 0.38
MAPT P10636 9/20 0.38
LMNA P02545 5/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
GPR35 Q9HC97 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
HTT P42858 4/20 0.37
NPC1 O15118 2/20 0.37
NPSR1 Q6W5P4 4/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MAPK1 P28482 2/20 0.35
NOD2 Q9HC29 1/20 0.35
TP53 P04637 2/20 0.34
TSHR P16473 2/20 0.34
MAPK10 P53779 2/20 0.34
PTK2B Q14289 1/20 0.34
NCOA1 Q15788 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28482241 0.94 LMNA (0.37) TDP1IDH1MAPTLMNACNR1
Bemotrizinol SCHEMBL29360093 0.93 TDP1 (0.43) TDP1IDH1MAPTLMNACNR1
Bemotrizinol SCHEMBL29350308 0.93 TDP1 (0.43) TDP1IDH1MAPTLMNACNR1
Bemotrizinol SCHEMBL77320 0.93 TDP1 (0.43) TDP1IDH1MAPTLMNACNR1
SCHEMBL10195000 0.93 TDP1 (0.43) TDP1IDH1MAPTLMNACNR1
SCHEMBL22854980 0.92 TDP1 (0.42) TDP1IDH1MAPTLMNACNR1
Bemotrizinol SCHEMBL26987980 0.90 TDP1 (0.39) TDP1IDH1MAPTLMNACNR1
SCHEMBL20024334 0.89 CNR1 (0.41) TDP1IDH1MAPTLMNACNR1
SCHEMBL12877715 0.89 TDP1 (0.39) TDP1IDH1MAPTLMNACNR1
SCHEMBL20778686 0.89 TDP1 (0.39) TDP1IDH1MAPTLMNACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1166759-A2 Use of lecithines to enhance the light protection factor and /or the UVA-protection of cosmetic or dermatologic light protection compositions Beiersdorf AG (DE) 2002-01-02 EP disclosed